Search
for
Sort by
Community 181–210 of 225
- INTEGRITY ISSUE - Melissa Toyos Verteporfin Treatment Marketing
- Fin and DMG, is the dmg actually gonna do something?
- M46 Getting fast hairline results
- New Hair Loss Cure: AMP-303 Is Back. It’s what PP405 should have been.
- Now that hair loss in mice is solved, can they move on to people?
- upcoming treatments that can be beneficial for those who can’t tolerate dht blockers?
- TH07 by Triple Hair entering phase III trial
- Do these baby hairs normally turn into longer hairs with time?
- 3 months on daily dutasteride 0,5 mg
- If all these vellus hairs turn terminal I’m gonna be a chewbacca
- How far away are we from scalp/hair follicle cloning for an essentially unlimited transplant supply? And would prior transplants affect eligibility?
- A positive thought rolling into Christmas
- What’s your views on clascoterone 5% topical solution by cosmo
- So was the Grey Market Breezula fake all along?
- Dermal incision with verteporfin
- P-1075: a BETTER version of Minoxidil
- Plant based hair growth serum shows visible results in <2 months. What do you think?
- Has anyone done research on Absci's AI‑driven antibody platform? Seeking your thoughts!
- Isn’t gt20029 more exciting from a maintenance and prevention perspective than pp405 as a true alternative to finasteride
- Life Extension - Hair Growth for Men
- Do you consider Haircafe a trusted source of news/discussion?
- We should actually be hopeful for these recent new developments
- Best Hair Regrowth Serum I have ever used
- Amplifica Sees Positive Results for Hair Loss Treatment - Results Show 15% increase in 60 days!
- Cbum's hair transplant looks absolutely terrible
- Amplifica’s AMP-303 Study Unveils New Hope for Hair Loss Treatments
- FCE 28260: A Forgotten 5α-Reductase Inhibitor
- Any updates on upcoming hair loss medication?
- Any news on potential hair loss treatments?
- HMI-115 update: Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia